Jordana Basagoiti-Munoz

Bellaterra, CT, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications

Distinct cytotoxic cell subsets underlie protective and non-protective immunity to African swine fever virus.

Distinct cytotoxic cell subsets underlie protective and non-protective immunity to African swine fever virus.

Journal: Emerging microbes & infections
Published: June 05, 2026

Adjuvant-induced macrophage activation compromises BA71ΔCD2-mediated protection against African swine fever virus.

Adjuvant-induced macrophage activation compromises BA71ΔCD2-mediated protection against African swine fever virus.

Journal: NPJ vaccines
Published: October 09, 2025

A human-ACE2 knock-in mouse model for SARS-CoV-2 infection recapitulates respiratory disorders but avoids neurological disease associated with the transgenic K18-hACE2 model.

A human-ACE2 knock-in mouse model for SARS-CoV-2 infection recapitulates respiratory disorders but avoids neurological disease associated with the transgenic K18-hACE2 model.

Journal: mBio
Published: April 24, 2025

Inactivated Rothia nasimurium promotes a persistent antiviral immune status in porcine alveolar macrophages.

Inactivated Rothia nasimurium promotes a persistent antiviral immune status in porcine alveolar macrophages.

Journal: Frontiers in immunology
Published: February 26, 2025

Elucidating the Onset of Cross-Protective Immunity after Intranasal Vaccination with the Attenuated African Swine Fever Vaccine Candidate BA71ΔCD2.

Elucidating the Onset of Cross-Protective Immunity after Intranasal Vaccination with the Attenuated African Swine Fever Vaccine Candidate BA71ΔCD2.

Journal: Vaccines
Published: April 08, 2024

Preclinical development of humanized monoclonal antibodies against CD169 as a broad antiviral therapeutic strategy.

Preclinical development of humanized monoclonal antibodies against CD169 as a broad antiviral therapeutic strategy.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: January 16, 2024

Novel Spike-stabilized trimers with improved production protect K18-hACE2 mice and golden Syrian hamsters from the highly pathogenic SARS-CoV-2 Beta variant.

Novel Spike-stabilized trimers with improved production protect K18-hACE2 mice and golden Syrian hamsters from the highly pathogenic SARS-CoV-2 Beta variant.

Journal: Frontiers in immunology
Published: September 10, 2023

Plitidepsin as an Immunomodulator against Respiratory Viral Infections.

Plitidepsin as an Immunomodulator against Respiratory Viral Infections.

Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: June 26, 2023

Immunization with V987H-stabilized Spike glycoprotein protects K18-hACE2 mice and golden Syrian hamsters upon SARS-CoV-2 infection.

Immunization with V987H-stabilized Spike glycoprotein protects K18-hACE2 mice and golden Syrian hamsters upon SARS-CoV-2 infection.

Journal: Nature communications
Published: April 21, 2023

Cyanovirin-N binds to select SARS-CoV-2 spike oligosaccharides outside of the receptor binding domain and blocks infection by SARS-CoV-2.

Cyanovirin-N binds to select SARS-CoV-2 spike oligosaccharides outside of the receptor binding domain and blocks infection by SARS-CoV-2.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: February 28, 2023

Self-sampling monkeypox virus testing in high-risk populations, asymptomatic or with unrecognized Mpox, in Spain.

Self-sampling monkeypox virus testing in high-risk populations, asymptomatic or with unrecognized Mpox, in Spain.

Journal: Nature communications
Published: February 06, 2023

β-Cyclodextrins as affordable antivirals to treat coronavirus infection.

β-Cyclodextrins as affordable antivirals to treat coronavirus infection.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: January 13, 2023
Showing 1-12 of 29

Last Updated: 09/26/2026